Cargando…
A head-to-head comparison of two DREADD agonists for suppressing operant behavior in rats via VTA dopamine neuron inhibition
RATIONALE: Designer receptors exclusively activated by designer drugs (DREADDs) are a tool for “remote control” of defined neuronal populations during behavior. These receptors are inert unless bound by an experimenter-administered designer drug, most commonly clozapine-n-oxide (CNO). However, quest...
Autores principales: | Lawson, Kate A, Ruiz, Christina M, Mahler, Stephen V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081263/ https://www.ncbi.nlm.nih.gov/pubmed/37034819 http://dx.doi.org/10.1101/2023.03.27.534429 |
Ejemplares similares
-
DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based
DREADDs in Vitro and in Vivo
por: Thompson, Karen J., et al.
Publicado: (2018) -
Behavioral effects of SGK1 knockout in VTA and dopamine neurons
por: Doyle, Marie A., et al.
Publicado: (2020) -
Periaqueductal efferents to dopamine and GABA neurons of the VTA
por: Ntamati, Niels R., et al.
Publicado: (2018) -
Mechanisms for multiple activity modes of VTA dopamine neurons
por: Oster, Andrew, et al.
Publicado: (2015) -
Correction: Periaqueductal efferents to dopamine and GABA neurons of the VTA
por: Ntamati, Niels R., et al.
Publicado: (2019)